Inside Aesthetics Ep 219 The Tox Talks (Chapter 6): Letybo/Letibotulinum Toxin | Professor Syed Haq
Episode 219 hosts Professor Syed Haq (Cosmetic Physician from London, UK)
Syed divides his time between preventative medicine & aesthetics. He has previously been an advisory board member for Ipsen, Allergan Aesthetics and is a Hugel Aesthetics KOL for Letybo.
In this mini series 'The Tox Talks', we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.
In chapter 6 we focus on a newly-launched product called Letybo (Letibotulinum Toxin A), a toxin produced by Hugel Aesthetics. Letybo is also known as Botulax and has been used in the Asian market since 2009.
We explore:
- Syed's training and career to date
- His role as a consultant for several pharma companies & most recently Hugel Aesthetics
- His insights into how the use of toxins has changed over the years
- The science behind Letybo
- The difference between vacuum dried & freeze dried toxins
- Some of the key outcomes of the Letybo clinical trials
- Syed's thoughts on a toxin's protein load & the incidence of toxin resistance
- Why the market needs more toxins
- Comparing units of different toxins - is this too simplisitc?
- How Letybo is reconstituted
- Why the depth of a toxin injection matters
- How a variety of factors can contribute to variable results
- How to introduce a new toxin choice to your patients
- What needles & syringes he prefers to use for toxins
- His thoughts on charging for toxins per area vs per unit